Alexander & Baldwin Rule 144 notice for 700-share sale
Rhea-AI Filing Summary
Alexander & Baldwin (ALEX) filed a Form 144 notice for a proposed sale of 700 common shares through UBS Financial Services, with an aggregate market value of $10,864.00. The filing lists an approximate sale date of 11/10/2025 on the NYSE.
The shares to be sold were acquired as compensation on 02/01/2023. The filing also reports recent sales by The Meredith J Ching Revocable Living Trust: 700 shares on 08/11/2025 for $12,700.80, 700 shares on 09/10/2025 for $13,128.78, and 700 shares on 10/10/2025 for $11,728.57. Shares outstanding were 72,758,460 as of the filing’s reference line.
This is a notice of intent to sell under Rule 144; actual sales and timing depend on market conditions and applicable Rule 144 limits.
Positive
- None.
Negative
- None.
Insights
Routine Rule 144 notice for a small proposed sale.
The filing discloses a planned sale of 700 ALEX common shares with an $10,864.00 aggregate market value via UBS Financial Services, targeted around 11/10/2025. The shares were originally acquired as compensation on 02/01/2023, aligning with Rule 144’s disclosure requirements.
Reported prior sales in the last three months were 700 shares each month with gross proceeds of $12,700.80, $13,128.78, and $11,728.57. Shares outstanding are stated at 72,758,460, indicating the proposed sale is small relative to the float based on the provided figures.
Rule 144 notices are administrative; market impact depends on execution and volume relative to trading. The filing lists NYSE as the exchange; the cash flow from any sale would accrue to the selling holder.
FAQ
What did ALEX disclose in this Form 144?
When is the proposed sale for ALEX shares expected?
How were the ALEX shares to be sold acquired?
Who has been selling ALEX shares recently under Rule 144?
What were the gross proceeds from recent ALEX sales?
How many ALEX shares are outstanding?